Trials / Completed
CompletedNCT00243724
HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease
An Open-Label, Parallel-Group, Multi-Centre Study to Determine the Effect of Treatment With Esomeprazole for Six Months on Histological Markers of Esophageal Epithelial Acid-Related Disease in Patients With Upper GI Symptoms.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 350 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine if different levels of acid-suppression with esomeprazole for 6 months on chosen histological markers of esophageal epithelial acid-related disease in patients with upper GI symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2005-10-25
- Last updated
- 2009-03-26
Locations
10 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00243724. Inclusion in this directory is not an endorsement.